Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate PK Profile”

70 trials

Showing 20 of 70 results

Early research (Phase 1)Not Yet RecruitingNCT07346690
What this trial is testing

A Study Testing the Effects of Different THC Doses on Psychological and Biological Function

Who this might be right for
Evaluate PK ProfileEvaluate PD ProfileHealthy Adults+1 more
University of Calgary 24
Early research (Phase 1)Study completedNCT00503490
What this trial is testing

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Amgen 40
Early research (Phase 1)Study completedNCT01610310
What this trial is testing

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
HealthyMultiple Sclerosis
Biogen 55
Early research (Phase 1)Study completedNCT04840849
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

Who this might be right for
Evaluate PK Profile
AstraZeneca 24
Early research (Phase 1)Study completedNCT04327765
What this trial is testing

Staccato® Granisetron Multiple Dose PK

Who this might be right for
Healthy
Alexza Pharmaceuticals, Inc. 30
Early research (Phase 1)Not Yet RecruitingNCT07462455
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Xiamen Amoytop Biotech Co., Ltd. 24
Early research (Phase 1)Study completedNCT00741273
What this trial is testing

Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults

Who this might be right for
Impaired Liver Function
Repros Therapeutics Inc. 16
Early research (Phase 1)Study completedNCT02710188
What this trial is testing

Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation

Who this might be right for
Alzheimer's Disease
Nxera Pharma UK Limited 14
Early research (Phase 1)Study completedNCT03424252
What this trial is testing

Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 11
Early research (Phase 1)Study completedNCT04120233
What this trial is testing

MW151-101: First-in-human Study of MW151

Who this might be right for
Drug Toxicity
Linda Van Eldik 40
Early research (Phase 1)Study completedNCT01243580
What this trial is testing

AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

Who this might be right for
Healthy
Agile Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT06542614
What this trial is testing

Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 209
Early research (Phase 1)UnknownNCT04862884
What this trial is testing

A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

Who this might be right for
Pain
Jiangsu HengRui Medicine Co., Ltd. 50
Early research (Phase 1)Study completedNCT00679835
What this trial is testing

PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections

Who this might be right for
Gram Positive InfectionConcurrent Antibiotic Treatment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Early research (Phase 1)Study completedNCT01800305
What this trial is testing

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

Who this might be right for
Healthy
Xiamen Amoytop Biotech Co., Ltd. 150
Early research (Phase 1)Ended earlyNCT05140824
What this trial is testing

Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
TJ Biopharma Co., Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT00394160
What this trial is testing

Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

Who this might be right for
Bronchiolitis
Organon and Co 12
Post-approval studies (Phase 4)Study completedNCT00148759
What this trial is testing

Kaletra Sex/Gender Pharmacokinetics (PK) Study

Who this might be right for
HIV Infections
Emory University 23
Early research (Phase 1)Active Not RecruitingNCT04143659
What this trial is testing

Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Who this might be right for
Healthy WomenFemale Contraception
Premier Research 136
Early research (Phase 1)Study completedNCT03714685
What this trial is testing

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Who this might be right for
Healthy Males
Quantum Genomics SA 12
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation